日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Surrogate endpoints for survival in KEYNOTE-585: neoadjuvant/adjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy for gastric or gastroesophageal junction adenocarcinoma

KEYNOTE-585研究中生存期的替代终点：新辅助/辅助帕博利珠单抗联合化疗与安慰剂联合化疗治疗胃癌或胃食管交界处腺癌的比较

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2026.106090
Shitara, K; Bang, Y-J; Wyrwicz, L S; Rha, S Y; Oshima, T; Pietrantonio, F; Park, Y-K; Lonardi, S; Yañez, P; Yen, C-J; Metges, J-P; Garrido, M; Moehler, M; Pelles-Avraham, S; Yong, W P; Spallanzani, A; Jensen, E; Krishnan, R; Shih, C-S; Al-Batran, S-E
胃癌
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Gastric Carcinoma: Diagnosis, Staging, and Treatment

胃癌：诊断、分期和治疗

期刊:Deutsches Arzteblatt International
影响因子:7.1
doi:10.3238/arztebl.m2025.0159
Huber, Yvonne; Unverzagt, Susanne; Lynen Jansen, Petra; Langer, Thomas; Nothacker, Monika; Moehler, Markus
胃癌
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Tislelizumab + Chemotherapy in Gastric Cancer: Long-Term RATIONALE-305 Randomized Trial Follow-up

替雷利珠单抗联合化疗治疗胃癌：RATIONALE-305随机试验的长期随访

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-025-03415-0
Cruz-Correa, Marcia; Oh, Do-Youn; Kato, Ken; Tabernero, Josep; Bai, Yuxian; Shi, Jianhua; Lee, Keun-Wook; Hirano, Hidekazu; Spigel, David; Wyrwicz, Lucjan; Pazo Cid, Roberto; Cubillo Gracián, Antonio; Xu, Yaling; Sheng, Tao; Yang, Silu; Xu, Rui-Hua; Moehler, Markus
胃癌
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

From consultation to choice: gynecologic cancer patients' perspectives on shared decision making in clinical practice - findings from a cross-sectional observational qualitative interview study

从咨询到选择：妇科癌症患者对临床实践中共同决策的看法——一项横断面观察性定性访谈研究的发现

期刊:BMC Medical Ethics
影响因子:3.1
doi:10.1186/s12910-026-01419-1
Theis, S; Frühwein, H; Hasenburg, A; Moehler, M; Paul, N W
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

PROMs: Patient related or patient centred? A bridge between Patient-Reported Outcome Measures (PROMs) and clinical ethics in the context of a cohort of gynaeco-oncological patients analysed by qualitative semi- structured interviews

患者报告结局指标：以患者为中心还是以患者为相关？通过对一组妇科肿瘤患者进行定性半结构式访谈，探讨患者报告结局指标（PROMs）与临床伦理之间的联系。

期刊:Journal of Patient-Reported Outcomes
影响因子:2.9
doi:10.1186/s41687-026-01050-z
Theis, Susanne; Fruehwein, Hamideh; Hasenburg, Annette; Moehler, Markus; Paul, Norbert W
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Nivolumab plus chemotherapy or ipilimumab in gastroesophageal cancer: exploratory biomarker analyses of a randomized phase 3 trial

纳武利尤单抗联合化疗或伊匹木单抗治疗胃食管癌：一项随机3期试验的探索性生物标志物分析

期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-025-03575-0
Shitara, Kohei; Janjigian, Yelena Y; Ajani, Jaffer; Moehler, Markus; Yao, Jin; Wang, Xuya; Chhibber, Aparna; Pandya, Dimple; Shen, Lin; Garrido, Marcelo; Gallardo, Carlos; Wyrwicz, Lucjan; Yamaguchi, Kensei; Skoczylas, Tomasz; Bragagnoli, Arinilda; Liu, Tianshu; Schenker, Michael; Yañez, Patricio; Kowalyszyn, Ruben; Karamouzis, Michalis; Zander, Thomas; Feeney, Kynan; Elimova, Elena; Doshi, Parul; Li, Mingshun; Lei, Ming
食管癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Efficacy and safety of bintrafusp alfa in 2 phase I expansion cohorts with advanced HCC

bintrafusp alfa 在 2 个 I 期扩展队列中治疗晚期肝细胞癌的疗效和安全性

期刊:Hepatology
影响因子:15.8
doi:10.1097/HEP.0000000000001054
Lim, Ho Yeong; Heo, Jeong; Peguero, Julio A; Ryoo, Baek-Yeol; Decaens, Thomas; Barlesi, Fabrice; Moehler, Markus H; Jehl, Genevieve; Eggleton, S Peter; Bajars, Marcis; Gulley, James L
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Comparative efficacy and safety of tislelizumab and other programmed cell death protein 1 inhibitors in first-line treatment of advanced gastroesophageal cancers: a systematic review and network meta-analysis

替雷利珠单抗与其他程序性细胞死亡蛋白1抑制剂一线治疗晚期胃食管癌的疗效和安全性比较：系统评价和网络荟萃分析

期刊:Gastric Cancer
影响因子:5.1
doi:10.1007/s10120-025-01660-4
Ajani, Jaffer A; Alsina, Maria; Moehler, Markus; Lee, Keun-Wook; Tang, Wenxi; Steenkamp, Jason; Prentiss, Emily; Wang, Kaijun; Hooper, Becky; Zhan, Lin
食管癌
肿瘤
肿瘤免疫
细胞生物学
发表日期：2025
文献求助 收藏

First-Line Tislelizumab Plus Chemotherapy for Advanced Gastric Cancer with Programmed Death-Ligand 1 Expression ≥ 1%: A Retrospective Analysis of RATIONALE-305

一线替雷利珠单抗联合化疗治疗程序性死亡配体1表达≥1%的晚期胃癌：RATIONALE-305研究的回顾性分析

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-025-03133-7
Moehler, Markus; Oh, Do-Youn; Kato, Ken; Arkenau, Tobias; Tabernero, Josep; Lee, Keun-Wook; Rha, Sun Young; Hirano, Hidekazu; Spigel, David; Yamaguchi, Kensei; Wyrwicz, Lucjan; Disel, Umut; Pazo-Cid, Roberto A; Fornaro, Lorenzo; Xu, Yaling; Sheng, Tao; Yang, Silu; Kadva, Alysha; Cruz-Correa, Marcia; Xu, Rui-Hua
胃癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Digital and AI-assisted multimodal supportive care, combining physical activity, nutrition, and pain management during chemotherapy for advanced pancreatic cancer patients: study protocol of the European multicenter randomized controlled trial of the RELEVIUM project

针对晚期胰腺癌患者，在化疗期间结合体育锻炼、营养和疼痛管理，采用数字化和人工智能辅助的多模式支持性护理：RELEVIUM 项目欧洲多中心随机对照试验的研究方案

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-14867-6
Hillen, Barlo; Oestreicher, Gabrielle; Schwab, Lisa; Enders, Kira; Simon, Perikles; Elme, Anneli; Ben-Aharon, Irit; Goshenlago, Tal; Neuzillet, Cindy; Sclafani, Francesco; Beltran, Eva Ester Molina; Schuster, Michael; Doncheva, Hristina; Ruckes, Christian; Karlecik, Michael; Petrowski, Katja; Rosenbaum, David; Diou, Christos; Ballas, Aristotelis; Vlachostergiou, Aggeliki; Mastricci, Davide; Scherrer, Alexander; Pilz, Maximilian; Flechsig, Jonas; Apostolidis, Lazaros; Krooupa, Anna-Maria; Chintha, Sai; Musisi, Isa Wasswa; Tzavara, Nefeli Panagiota; Kakasis, Athanasios; Hadjikypri, Xenia; Karra, Styliani; Chatzipanagiotou, Kyriaki; Drivas, Ioannis; Dacasa, Hugo; Moehler, Markus
胰腺癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏